Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03304652 · ClinicalTrials.gov registry record
Cerebral MRI During Sleep
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 11
- Enrollment target
NCT03304652 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 11 participants.
The verdict
NCT03304652 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
Recent studies in animal models have suggested a critical role for cerebrospinal fluid and Interstitial fluid flux through cerebral parenchyma for removal of byproducts of cellular metabolism and hence in maintaining the health of the brain. This effect is modulated during sleep, suggesting a potentially important mechanism for sleep to maintain both acute homeostasis and long-term cerebral health. The central goal of these studies is to develop a sensitive MRI biomarker of cerebral conformational changes during sleep. This exploratory work aims to establish the sensitivity and reproducibility of MRI as a non-invasive neuroimaging assessment of cerebral changes during natural sleep and sedation.
Interventions
- DRUG Zaleplon
- OTHER Natural Sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2018-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03304652
The ClinicalTrials.gov registry entry for NCT03304652 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Zaleplon is the first listed.
NCT03304652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03304652 about?
NCT03304652 is a clinical study titled "Cerebral MRI During Sleep". Recent studies in animal models have suggested a critical role for cerebrospinal fluid and Interstitial fluid flux through cerebral parenchyma for removal of byproducts of cellular metabolism and hence in maintaining the health of the brain. This effect is modulated during sleep, suggesting a potent...
What is the current status of trial NCT03304652?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2017-10-01. Estimated completion is 2018-10-31.
What interventions are being tested in trial NCT03304652?
The interventions under investigation include: Zaleplon (DRUG), Natural Sleep (OTHER).
Who is sponsoring clinical trial NCT03304652?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.